Trial Profile
Phase II exploratory study of brostallicin PNU-166196A as third/fourth line chemotherapy in adult patients with advanced/metastatic colorectal cancer CRC .
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 May 2011
Price :
$35
*
At a glance
- Drugs Brostallicin (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 17 May 2011 New trial record